• Home
• Contact
• Plan du site

Moyamoya publications

• Measuring Cerebral Blood Flow in Moyamoya Angiopathy by Quantitative Magnetic Resonance Angiography Noninvasive Optimal Vessel Analysis.
  Khan N, Lober RM, Ostergren L, Petralia J, Bell-Stephens T, Navarro R, Feroze A, Steinberg GK. Neurosurgery. 2017 Feb 14. doi: 10.1093/neuros/nyw122. [Epub ahead of print] No abstract available.
  
  
• Research Progresses in Understanding the Pathophysiology of Moyamoya Disease.
  Bersano A, Guey S, Bedini G, Nava S, Hervé D, Vajkoczy P, Tatlisumak T, Sareela M, van der Zwan A, Klijn CJ, Braun KP, Kronenburg A, Acerbi F, Brown MM, Calviere L, Cordonnier C, Henon H, Thines L, Khan N, Czabanka M, Kraemer M, Simister R, Prontera P, Tournier-Lasserve E, Parati E; European Moyamoya Disease Initiative. Cerebrovasc Dis. 2016;41(3-4):105-18. doi: 10.1159/000442298. Review.

• Quantitative H2[(15)O]-PET in Pediatric Moyamoya Disease: Evaluating Perfusion before and after Cerebral Revascularization.
  Kuhn FP, Warnock G, Schweingruber T, Sommerauer M, Buck A, Khan N.
  J Stroke Cerebrovasc Dis. 2015 May;24(5):965-71. doi: 10.1016/j.jstrokecerebrovasdis.2014.12.017. Epub 2015 Mar 23.
  
  
• The collateral circulation in pediatric moyamoya disease.
  Baltsavias G, Khan N, Valavanis A.
  Childs Nerv Syst. 2015 Mar;31(3):389-98. doi: 10.1007/s00381-014-2582-5. Epub 2014 Nov 7.
  
  
• Selective and superselective angiography of pediatric moyamoya disease angioarchitecture in the posterior circulation.
  Baltsavias G, Khan N, Filipce V, Valavanis A. Interv Neuroradiol. 2014 Jul-Aug;20(4):403-12. doi: 10.15274/NRJ-2014-10041. Epub 2014 Aug 28.
  
  
• Selective and superselective angiography of pediatric moyamoya disease angioarchitecture in the posterior circulation.
  Baltsavias G, Khan N, Filipce V, Valavanis A.
  Interv Neuroradiol. 2014 Jul-Aug;20(4):403-12. doi: 10.15274/NRJ-2014-10041. Epub 2014 Aug 28.

• Quantitative Cerebral Perfusion Imaging in Children and Young Adults with Moyamoya Disease: Comparison of Arterial Spin-Labeling-MRI and H2[15O]-PET.
  Goetti R, Warnock G, Kuhn FP, Guggenberger R, O'Gorman R, Buck A, Khan N, Scheer I. AJNR Am J Neuroradiol. 2013 Dec 12.
  
  
• Arterial spin labelling MRI for assessment of cerebral perfusion in children with moyamoya disease: comparison with dynamic susceptibility contrast MRI.
  Goetti R, O'Gorman R, Khan N, Kellenberger CJ, Scheer I.
  Neuroradiology. 2013 May;55(5):639-47. doi: 10.1007/s00234-013-1155-8. Epub 2013 Feb 13.
  
  
• In reply. The genetics of moyamoya disease: recent insights into the pathogenesis of the disease.
  Achrol AS, Khan N, Steinberg GK.
  Neurosurgery. 2013 Feb;72(2):E321-2. doi: 10.1227/NEU.0b013e31827bc1c1. No abstract available.
  
  
• Differential diagnosis between cerebral ischemia, focal seizures and limb shaking TIAs in moyamoya disease.
  Kraemer M, Diehl RR, Diesner F, Berlit P, Khan N.
  Br J Neurosurg. 2012 Dec;26(6):896-8. doi: 10.3109/02688697.2012.697213. Epub 2012 Jun 29.
  
  
• Sex differences in clinical presentation and treatment outcomes in Moyamoya disease.
  Khan N, Achrol AS, Guzman R, Burns TC, Dodd R, Bell-Stephens T, Steinberg GK.
  Neurosurgery. 2012 Sep;71(3):587-93; discussion 593. doi: 10.1227/NEU.0b013e3182600b3c.
  
  
• Analysis of TGFB1 in European and Japanese Moyamoya disease patients.
  Liu C, Roder C, Schulte C, Kasuya H, Akagawa H, Nishizawa T, Yoneyama T, Okada Y, Khan N, Tatagiba M, Berg D, Krischek B.
  Eur J Med Genet. 2012 Oct;55(10):531-4. doi: 10.1016/j.ejmg.2012.05.002. Epub 2012 Jun 1.
  
  
• Postoperative changes in the superficial temporal artery and the external carotid artery duplex sonography after extra-intracranial bypass surgery in European Moyamoya disease.
  Kraemer M, Schuknecht B, Jetzer AK, Yonekawa Y, Khan N.
  Clin Neurol Neurosurg. 2012 Sep;114(7):930-4. doi: 10.1016/j.clineuro.2012.02.004. Epub 2012 Apr 4.
  
  
• Analysis of human leucocyte antigen genes in Caucasian patients with idiopathic moyamoya angiopathy.
  Kraemer M, Horn PA, Roder C, Khan N, Diehl RR, Berlit P, Heinemann FM.
  Acta Neurochir (Wien). 2012 Mar;154(3):445-54. doi: 10.1007/s00701-011-1261-5. Epub 2012 Jan 11.
  
  
• Operative neurosurgery: personal view and historical backgrounds (9) Moyamoya angiopathy (MMA): past history and status presens].
  Yonekawa Y.
  2012 Jan;40(1):67-87. Japanese. No Shinkei Geka.
  
  
• Inheritance of moyamoya disease in a Caucasian family.
  Kraemer M, Heinemann FM, Horn PA, Venker C, Berlit P, Krischek B, Khan N.
  Eur J Neurol. 2012 Mar;19(3):438-42. doi: 10.1111/j.1468-1331.2011.03536.x. Epub 2011 Oct 4.
  
  
• Genetic and clinical characteristics of Moyamoya disease in Europeans.
  Krischek B, Kasuya H, Khan N, Tatagiba M, Roder C, Kraemer M.
  Acta Neurochir Suppl. 2011;112:31-4. doi: 10.1007/978-3-7091-0661-7_6.
  
  
• What is the expert's option on antiplatelet therapy in moyamoya disease? Results of a worldwide Survey.
  Kraemer M, Berlit P, Diesner F, Khan N.
  Eur J Neurol. 2012 Jan;19(1):163-7. doi: 10.1111/j.1468-1331.2011.03481.x. Epub 2011 Jul 20.
  
  
• Failure of primary percutaneous angioplasty and stenting in the prevention of ischemia in Moyamoya angiopathy.
  Khan N, Dodd R, Marks MP, Bell-Stephens T, Vavao J, Steinberg GK.
  Cerebrovasc Dis. 2011;31(2):147-53. doi: 10.1159/000320253. Epub 2010 Dec 4.
  
  
• Analysis of ACTA2 in European Moyamoya disease patients.
  Roder C, Peters V, Kasuya H, Nishizawa T, Wakita S, Berg D, Schulte C, Khan N, Tatagiba M, Krischek B.
  Eur J Paediatr Neurol. 2011 Mar;15(2):117-22. doi: 10.1016/j.ejpn.2010.09.002. Epub 2010 Oct 20.
  
  
• Genetics of Moyamoya disease.
  Roder C, Nayak NR, Khan N, Tatagiba M, Inoue I, Krischek B.
  J Hum Genet. 2010 Nov;55(11):711-6. doi: 10.1038/jhg.2010.103. Epub 2010 Aug 26.
  
  
• Common genetic polymorphisms in moyamoya and atherosclerotic disease in Europeans.
  Roder C, Peters V, Kasuya H, Nishizawa T, Takehara Y, Berg D, Schulte C, Khan N, Tatagiba M, Krischek B.
  Childs Nerv Syst. 2011 Feb;27(2):245-52. doi: 10.1007/s00381-010-1241-8. Epub 2010 Aug 6.
  
  
• Polymorphisms in TGFB1 and PDGFRB are associated with Moyamoya disease in European patients.
  Roder C, Peters V, Kasuya H, Nishizawa T, Takehara Y, Berg D, Schulte C, Khan N, Tatagiba M, Krischek B.
  Acta Neurochir (Wien). 2010 Dec;152(12):2153-60. doi: 10.1007/s00701-010-0711-9. Epub 2010 Jun 23.
  
  
• Majewski osteodysplastic primordial dwarfism type II (MOPD II): expanding the vascular phenotype.
  Bober MB, Khan N, Kaplan J, Lewis K, Feinstein JA, Scott CI Jr, Steinberg GK.
  Am J Med Genet A. 2010 Apr;152A(4):960-5. doi: 10.1002/ajmg.a.33252.
  
  
• Moyamoya angiopathy in Europe: the beginnings in Zurich, practical lessons learned, increasing awareness and future perspectives.
  Khan N, Yonekawa Y.
  Acta Neurochir Suppl. 2008;103:127-30. Review.
  
  
• Moyamoya syndrome associated with hemolytic anemia due to Hb Alesha.
  Brockmann K, Stolpe S, Fels C, Khan N, Kulozik AE, Pekrun A.
  J Pediatr Hematol Oncol. 2005 Aug;27(8):436-40.
  
  
• Moyamoya angiopathy in Europe.
  Khan N, Yonekawa Y.
  Acta Neurochir Suppl. 2005;94:149-52.
  
  
• Constant-infusion H(2)15O PET and acetazolamide challenge in the assessment of cerebral perfusion status.
  Weber B, Westera G, Treyer V, Burger C, Khan N, Buck A.
  J Nucl Med. 2004 Aug;45(8):1344-50.
  
  
• Moyamoya angiopathy with dolichoectatic internal carotid arteries, patent ductus arteriosus and pupillary dysfunction: a new genetic syndrome?
  Khan N, Schinzel A, Shuknecht B, Baumann F, Østergaard JR, Yonekawa Y.
  Eur Neurol. 2004;51(2):72-7. Epub 2004 Jan 16.
  
  
• Moyamoya disease and Moyamoya syndrome: experience in Europe; choice of revascularisation procedures.
  Khan N, Schuknecht B, Boltshauser E, Capone A, Buck A, Imhof HG, Yonekawa Y.
  Acta Neurochir (Wien). 2003 Dec;145(12):1061-71; discussion 1071. Epub 2003 Dec 4.
  
  
• Metabolic changes after H(2) 15O-positron emission tomography with acetazolamide in a patient with moyamoya disease: case report and review of previous cases.
  Muroi C, Yonekawa Y, Khan N, Pangalu A, Keller E.
  J Neurosurg Anesthesiol. 2003 Apr;15(2):131-9.
  
  
• Severe arterial occlusive disorder and brachysyndactyly in a boy: a further case of Grange syndrome?
  Weymann S, Yonekawa Y, Khan N, Martin E, Heppner FL, Schinzel A, Kotzot D.
  Am J Med Genet. 2001 Mar 15;99(3):190-5.